Prelude Therapeutics Inc insider trading
PRLD$3.77+0.10 (+2.72% today)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (+158.2%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Unlock quarterly net flowKey players
- KVKrishna Vaddi4.5976%
- DPDavid P. Bonita2.0706%
- ACAndrew Combs0.6016%
- SPSean P. Brusky0.1253%
- JHJane Huang0.1089%
- BDBryant David Lim0.0343%
- RCRa Capital Management, L.P.Not reported
- OGOrbiMed Genesis GP LLCNot reported
- RMRajeev M. ShahNot reported
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| PRLD | David P. Bonita | Open market purchase$5M | Not reported | $4.44 | $5M | Apr 21, 2026 | Apr 23, 2026 |
| PRLD | David P. Bonita | Open market purchase$7.5M | +16.7% | $4.44 | $7.5M | Apr 21, 2026 | Apr 23, 2026 |
| PRLD | OrbiMed Genesis GP LLC | Open market purchase$5M | Not reported | $4.44 | $5M | Apr 21, 2026 | Apr 23, 2026 |
| PRLD | OrbiMed Genesis GP LLC | Open market purchase$7.5M | +16.7% | $4.44 | $7.5M | Apr 21, 2026 | Apr 23, 2026 |